DANIELLE BORLAND: Open Payments
NPI 1164132841 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,985 in 23 payments from 9 companies in 2025. Trend: 2023 $398 · 2024 $255 · 2025 $1,985
Consulting: $1,350Food & beverage: $558Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $1,624 |
| Madrigal Pharmaceuticals | 4 | $155 |
| Phathom Pharmaceuticals, Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $54 |
| Novo Nordisk Inc | 1 | $21 |
| Ardelyx, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| EVOKE PHARMA, INC. | 1 | $16 |
| QOL Medical, LLC | 1 | $14 |
Products named: TREMFYA, REZDIFFRA, VOQUEZNA, LINZESS, Wegovy, IBSRELA, ZEPBOUND, RINVOQ.
Industry payments across FL — which companies pay providers there.
